The progress in C9orf72 research: ALS/FTD pathogenesis, functions and structure

References

• DeJesus-Hernandez M, Mackenzie I, Boeve B, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256.
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257–268.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Jiang J, Gendron TF, et al. Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72. Nat Neurosci. 2020;23:615–624.
   PubMed Web of Science ®Google Scholar
• Shi Y, Lin S, Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313–325.
   PubMed Web of Science ®Google Scholar
• Kwon I, Xiang S, Kato M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345:1139–1145.
   PubMed Web of Science ®Google Scholar
• Haeusler AR, Donnelly CJ, Periz G, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195–200.
   PubMed Web of Science ®Google Scholar
• Hayes LR, Rothstein JD. C9ORF72-ALS/FTD: transgenic mice make a come-BAC. Neuron. 2016;90:427–431.
   PubMed Web of Science ®Google Scholar
• Conlon EG, Lu L, Sharma A, et al. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016;5: DOI:10.7554/eLife.17820
   PubMed Web of Science ®Google Scholar
• Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14:544–558.
   PubMed Web of Science ®Google Scholar
• Mori K, Weng S-M, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339(6125):1335–1338.
   PubMed Web of Science ®Google Scholar
• Mizielinska S, Gronke S, Niccoli T, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192–1194.
   PubMed Web of Science ®Google Scholar
• Freibaum BD, Lu Y, Lopez-Gonzalez R, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129–133.
   PubMed Web of Science ®Google Scholar
• Chew J, Gendron TF, Prudencio M, et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151–1154.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Gendron TF, Grima JC, et al. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins. Nat Neurosci. 2016;19:668–677.
   PubMed Web of Science ®Google Scholar
• Lee KH, Zhang P, Kim HJ, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774–788 e717.
   PubMed Web of Science ®Google Scholar
• Guo Q, Lehmer C, Martinez-Sanchez A, et al. In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell. 2018;172:696–705 e612.
   PubMed Web of Science ®Google Scholar
• Hao Z, Liu L, Tao Z, et al. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat Commun. 2019;10:2906.
   PubMed Web of Science ®Google Scholar
• Wang R, Xu X, Hao Z, et al. Poly-PR in C9ORF72-related amyotrophic lateral sclerosis/frontotemporal dementia causes neurotoxicity by clathrin-dependent endocytosis. Neurosci Bull. 2019;35:889–900.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Guo L, Gonzales PK, et al. Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity. Science. 2019;363: DOI:10.1126/science.aav2606
   Web of Science ®Google Scholar
• Farg MA, Sundaramoorthy V, Sultana JM, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23:3579–3595.
   PubMed Web of Science ®Google Scholar
• Yang M, Liang C, Swaminathan K, et al. A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci Adv. 2016;2:e1601167.
   PubMed Web of Science ®Google Scholar
• Sellier C, Campanari ML, Corbier CJ, et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. Embo J. 2016;35:1276–1297.
   PubMed Web of Science ®Google Scholar
• Webster CP, Smith EF, Bauer CS, et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. Embo J. 2016;35:1656–1676.
   PubMed Web of Science ®Google Scholar
• Jung J, Nayak A, Schaeffer V, et al. Multiplex image-based autophagy RNAi screening identifies SMCR8 as ULK1 kinase activity and gene expression regulator. Elife. 2017;6: DOI:10.7554/eLife.23063
   Web of Science ®Google Scholar
• Amick J, Roczniak-Ferguson A, Ferguson SM. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol Biol Cell. 2016;27:3040–3051.
   PubMed Web of Science ®Google Scholar
• Sullivan PM, Zhou X, Robins AM, et al. The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol Commun. 2016;4:51.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Burberry A, Wang JY, et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 2018;32:929–943.
   PubMed Web of Science ®Google Scholar
• Trageser KJ, Smith C, Herman FJ, et al. Mechanisms of immune activation by c9orf72-expansions in amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2019;13:1298.
   PubMed Web of Science ®Google Scholar
• Lai JD, Ichida JK. C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis. Neurosci Lett. 2019;713:134523.
   PubMed Web of Science ®Google Scholar
• Yoshimura S, Gerondopoulos A, Linford A, et al. Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. J Cell Biol. 2010;191:367–381.
   PubMed Web of Science ®Google Scholar
• Wu X, Bradley MJ, Cai Y, et al. Insights regarding guanine nucleotide exchange from the structure of a DENN-domain protein complexed with its Rab GTPase substrate. Proc Natl Acad Sci U S A. 2011;108:18672–18677.
   PubMed Web of Science ®Google Scholar
• Marat AL, Dokainish H, McPherson PS. DENN domain proteins: regulators of Rab GTPases. J Biol Chem. 2011;286:13791–13800.
   PubMed Web of Science ®Google Scholar
• Levine TP, Danials RD, Wong LH, et al. Discovery of new Longin and Roadblock domains that form platforms for small GTPases in Ragulator and TRAPP-II. Small GTPases. 2013;4:62–69.
   PubMedGoogle Scholar
• Zhang D, Iyer LM, He F, et al. Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front Genet. 2012;3:283.
   PubMedGoogle Scholar
• Levine TP, Daniels RD, Gatta AT, et al. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics. 2013;29:499–503.
   PubMed Web of Science ®Google Scholar
• Levivier E, Goud B, Souchet M, et al. uDENN, DENN, and dDENN: indissociable domains in Rab and MAP kinases signaling pathways. Biochem Biophys Res Commun. 2001;287:688–695.
   PubMed Web of Science ®Google Scholar
• Shen K, Rogala KB, Chou HT, et al. Cryo-EM structure of the human FLCN-FNIP2-Rag-ragulator complex. Cell. 2019;179:1319–1329 e1318.
   PubMed Web of Science ®Google Scholar
• Tang D, Sheng J, Xu L, et al. Cryo-EM structure of C9ORF72-SMCR8-WDR41 reveals the role as a GAP for Rab8a and Rab11a. Proc Natl Acad Sci U S A. 2020;117:9876–9883.
   PubMed Web of Science ®Google Scholar
• Su M-Y, Fromm SA, Zoncu R, et al. Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD. Nature. 2020;585:251–255.
   PubMed Web of Science ®Google Scholar
• Tang D, Sheng J, Xu L, et al. The C9orf72-SMCR8-WDR41 complex is a GAP for small GTPases. Autophagy. 2020. DOI:10.1080/15548627.2020.1779473
   Web of Science ®Google Scholar
• Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162–172.
   PubMed Web of Science ®Google Scholar
• Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006;7:710–723.
   PubMed Web of Science ®Google Scholar
• Kim G, Gautier O, Tassoni-Tsuchida E, et al. Implications for future therapies. Neuron. 2020;108:822–842.
   PubMed Web of Science ®Google Scholar
• Norris SP, Likanje MN, Andrews JA. Amyotrophic lateral sclerosis: update on clinical management. Curr Opin Neurol. 2020;33:641–648.
   PubMed Web of Science ®Google Scholar
• Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med. 1994;330:585–591.
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, et al. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology. 1996;47:S242–250.
   PubMed Web of Science ®Google Scholar
• Andrews JA, Jackson CE, Heiman-Patterson TD, et al. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:509–518.
   PubMed Web of Science ®Google Scholar
• Smith R, Pioro E, Myers K, et al. Enhanced bulbar function in amyotrophic lateral sclerosis: the nuedexta treatment trial. Neurotherapeutics. 2017;14:762–772.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Thisted RA, Appel SH, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine. A Randomized Trial. 2004;63:1364–1370.
   Google Scholar
• Writing G, Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505–512.
   PubMed Web of Science ®Google Scholar
• Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24:S320-S326.
   Google Scholar
• Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
   PubMed Web of Science ®Google Scholar
• van Rheenen W, Shatunov A, Dekker AM, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48:1043–1048.
   PubMed Web of Science ®Google Scholar
• Hulisz D. Amyotrophic lateral sclerosis: disease state overview. Am J Manag Care. 2018;24:S320–s326.
   PubMed Web of Science ®Google Scholar
• Vance C, Al-Chalabi A, Ruddy D, et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain. 2006;129:868–876.
   PubMed Web of Science ®Google Scholar
• Morita M, Al-Chalabi A, Andersen PM, et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006;66:839–844.
   PubMed Web of Science ®Google Scholar
• Jung J, Behrends C. Multifaceted role of SMCR8 as autophagy regulator. Small GTPases. 2020;11:53–61.
   PubMedGoogle Scholar
• Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016;17:383–395.
   PubMed Web of Science ®Google Scholar
• Burguete AS, Almeida S, Gao FB, et al. GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. Elife. 2015;4:e08881.
   PubMed Web of Science ®Google Scholar
• Jiang J, Zhu Q, Gendron TF, et al. Gain of Toxicity from ALS/FTD-linked repeat expansions in C9ORF72 Is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron. 2016;90:535–550.
   PubMed Web of Science ®Google Scholar
• Gendron TF, Petrucelli L. Disease Mechanisms of C9ORF72 Repeat Expansions. Cold Spring Harb Perspect Med. 2018;8: DOI:10.1101/cshperspect.a024224
   PubMed Web of Science ®Google Scholar
• Chan YA, Aristizabal MJ, Lu PY, et al. Genome-wide profiling of yeast DNA:RNA hybrid prone sites with DRIP-chip. PLoS Genet. 2014;10:e1004288.
   PubMed Web of Science ®Google Scholar
• Aguilera A, Garcia-Muse T. R loops: from transcription byproducts to threats to genome stability. Mol Cell. 2012;46:115–124.
   PubMed Web of Science ®Google Scholar
• Zu T, Liu Y, Banez-Coronel M, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A. 2013;110:E4968–4977.
   PubMed Web of Science ®Google Scholar
• Babic Leko M, Zupunski V, Kirincich J, et al. Molecular mechanisms of neurodegeneration related to C9orf72 hexanucleotide repeat expansion. Behav Neurol. 2019;2019:2909168.
   PubMed Web of Science ®Google Scholar
• Jovicic A, Mertens J, Boeynaems S, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18:1226–1229.
   PubMed Web of Science ®Google Scholar
• Ciura S, Lattante S, Ber IL, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol. 2013;74:180–187.
   PubMed Web of Science ®Google Scholar
• Therrien M, Rouleau GA, Dion PA, et al. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS One. 2013;8:e83450.
   PubMed Web of Science ®Google Scholar
• McAlpine W, Sun L, Wang KW, et al. Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function. Proc Natl Acad Sci U S A. 2018;115:E11523–E11531.
   PubMed Web of Science ®Google Scholar
• Shao Q, Yang M, Liang C, et al. C9orf72 and smcr8 mutant mice reveal MTORC1 activation due to impaired lysosomal degradation and exocytosis. Autophagy. 2019;1–16. DOI:10.1080/15548627.2019.1703353
   Web of Science ®Google Scholar
• Xiao S, McKeever PM, Lau A, et al. Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels. Acta Neuropathol Commun. 2019;7:161.
   PubMed Web of Science ®Google Scholar
• Sreedharan J, Blair IP, Tripathi VB, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668–1672.
   PubMed Web of Science ®Google Scholar
• Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–416.
   PubMed Web of Science ®Google Scholar
• Chio A, Calvo A, Mazzini L, et al. Extensive genetics of ALS: a population-based study in Italy. Neurology. 2012;79:1983–1989.
   PubMed Web of Science ®Google Scholar
• Corcia P, Valdmanis P, Millecamps S, et al. Phenotype and genotype analysis in amyotrophic lateral sclerosis with TARDBP gene mutations. Neurology. 2012;78:1519–1526.
   PubMed Web of Science ®Google Scholar
• Sleigh JN, Tosolini AP, Gordon D, et al. Mice carrying ALS mutant TDP-43, but not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep. 2020;30:3655–3662 e3652.
   PubMed Web of Science ®Google Scholar
• Wong P, Ho WY, Yen YC, et al. The vulnerability of motor and frontal cortex-dependent behaviors in mice expressing ALS-linked mutation in TDP-43. Neurobiol Aging. 2020;92:43–60.
   PubMed Web of Science ®Google Scholar
• Sieverding K, Ulmer J, Bruno C, et al. Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43(G298S) transgenic mice. Exp Neurol. 2021;335:113496.
   PubMed Web of Science ®Google Scholar
• Tsao W, Jeong YH, Lin S, et al. Rodent models of TDP-43: recent advances. Brain Res. 2012;1462:26–39.
   PubMed Web of Science ®Google Scholar
• Ayala YM, Zago P, Ambrogio AD, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci. 2008;121:3778–3785.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133.
   PubMed Web of Science ®Google Scholar
• Ling SC. Synaptic Paths to Neurodegeneration: the Emerging Role of TDP-43 and FUS in Synaptic Functions. Neural Plast. 2018;2018:8413496.
   PubMed Web of Science ®Google Scholar
• Lattante S, Rouleau GA, Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat. 2013;34:812–826.
   PubMed Web of Science ®Google Scholar
• Armakola M, Higgins MJ, Figley MD, et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet. 2012;44:1302–1309.
   PubMed Web of Science ®Google Scholar
• Elden AC, Kim HJ, Hart MP, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–1075.
   PubMed Web of Science ®Google Scholar
• Ash PE, Zhang YJ, Roberts CM, et al. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet. 2010;19:3206–3218.
   PubMed Web of Science ®Google Scholar
• Liachko NF, Guthrie CR, Kraemer BC. Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci. 2010;30:16208–16219.
   PubMed Web of Science ®Google Scholar
• Kabashi E, Lin L, Tradewell ML, et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet. 2010;19:671–683.
   PubMed Web of Science ®Google Scholar
• Laird AS, Hoecke AV, Muynck LD, et al. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS One. 2010;5:e13368.
   PubMed Web of Science ®Google Scholar
• Picher-Martel V, Valdmanis PN, Gould PV, et al. From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathol Commun. 2016;4:70.
   PubMed Web of Science ®Google Scholar
• Gordon D, Dafinca R, Scaber J, et al. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiol Dis. 2019;121:148–162.
   PubMed Web of Science ®Google Scholar
• Kraemer BC, Schuck T, Wheeler JM, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119:409–419.
   PubMed Web of Science ®Google Scholar
• Sephton CF, Good SK, Atkin S, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem. 2010;285:6826–6834.
   PubMed Web of Science ®Google Scholar
• Wu LS, Cheng WC, Hou SC, et al. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis. 2010;48:56–62.
   PubMed Web of Science ®Google Scholar
• Swarup V, Phaneuf D, Bareil C, et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134:2610–2626.
   PubMed Web of Science ®Google Scholar
• Arnold ES, Ling SC, Huelga SC, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A. 2013;110:E736–745.
   PubMed Web of Science ®Google Scholar
• Xu YF, Gendron TF, Zhang YJ, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010;30:10851–10859.
   PubMed Web of Science ®Google Scholar
• Liu YC, Chiang PM, Tsai KJ. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci. 2013;14:20079–20111.
   PubMed Web of Science ®Google Scholar
• Wegorzewska I, Bell S, Cairns NJ, et al. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106:18809–18814.
   PubMed Web of Science ®Google Scholar
• Mitchell JC, Constable R, So E, et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol Commun. 2015;3(1):36.
   PubMedGoogle Scholar
• Esmaeili MA, Panahi M, Yadav S, et al. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol. 2013;94(1):56–64.
   PubMed Web of Science ®Google Scholar
• Hatzipetros T, Bogdanik LP, Tassinari VR, et al. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59–72.
   PubMed Web of Science ®Google Scholar
• White MA, Lin Z, Kim E, et al. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathol Commun. 2019;7:166.
   PubMed Web of Science ®Google Scholar
• Ebstein SY, Yagudayeva I, Shneider NA. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 2019;26:364–373 e364.
   PubMed Web of Science ®Google Scholar
• Walker AK, Spiller KJ, Ge G, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643–660.
   PubMed Web of Science ®Google Scholar
• Igaz LM, Kwong L, Lee EB, et al. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest. 2011;121:726–738.
   PubMed Web of Science ®Google Scholar
• Alfieri JA, Pino NS, Igaz LM. Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies. J Neurosci. 2014;34:15244–15259.
   PubMed Web of Science ®Google Scholar
• Chai N, Gitler AD. Yeast screen for modifiers of C9orf72 poly(glycine-arginine) dipeptide repeat toxicity. FEMS Yeast Res. 2018;18: DOI:10.1093/femsyr/foy024
   PubMed Web of Science ®Google Scholar
• Furuta N, Tsukagoshi S, Hirayanagi K, et al. Suppression of the yeast elongation factor Spt4 ortholog reduces expanded SCA36 GGCCUG repeat aggregation and cytotoxicity. Brain Res. 2019;1711:29–40.
   PubMed Web of Science ®Google Scholar
• Gois AM, Mendonca DMF, Freire MAM, et al. In vitro and in vivo models of amyotrophic lateral sclerosis: an updated overview. Brain Res Bull. 2020;159:32–43.
   PubMed Web of Science ®Google Scholar
• Corrionero A, Horvitz HR, C9orf72 A. ALS/FTD ortholog acts in endolysosomal degradation and lysosomal homeostasis. Curr Biol. 2018;28:1522–1535 e1525.
   PubMed Web of Science ®Google Scholar
• Ji YJ, Ugolino J, Zhang T, et al. C9orf72/ALFA-1 controls TFEB/HLH-30-dependent metabolism through dynamic regulation of Rag GTPases. PLoS Genet. 2020;16:e1008738.
   PubMed Web of Science ®Google Scholar
• Yuva-Aydemir Y, Almeida S, Gao FB. Insights into C9ORF72-Related ALS/FTD from Drosophila and iPSC Models. Trends Neurosci. 2018;41:457–469.
   PubMed Web of Science ®Google Scholar
• Olesnicky EC, Wright EG. Drosophila as a model for assessing the function of RNA-binding proteins during neurogenesis and neurological disease. J Dev Biol. 2018;6: DOI:10.3390/jdb6030021
   PubMed Web of Science ®Google Scholar
• Tran H, Almeida S, Moore J, et al. Differential toxicity of nuclear RNA Foci versus dipeptide repeat proteins in a drosophila model of C9ORF72 FTD/ALS. Neuron. 2015;87:1207–1214.
   PubMed Web of Science ®Google Scholar
• Fortier G, Butti Z, Patten SA. Modelling C9orf72-related amyotrophic lateral sclerosis in zebrafish. Biomedicines. 2020;8: DOI:10.3390/biomedicines8100440
   PubMed Web of Science ®Google Scholar
• Yeh TH, Liu HF, Li YW, et al. C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1. Exp Neurol. 2018;304:114–124.
   PubMed Web of Science ®Google Scholar
• Butti Z, Patten K. GJ. Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish. Research Square. 2020. DOI:10.21203/rs.3.rs-49118/v1
   Google Scholar
• Giacomotto J, Rinkwitz S, Becker TS. Effective heritable gene knockdown in zebrafish using synthetic microRNAs. Nat Commun. 2015;6:7378.
   PubMed Web of Science ®Google Scholar
• Ho WY, Navakkode S, Liu F, et al. Deregulated expression of a longevity gene, Klotho, in the C9orf72 deletion mice with impaired synaptic plasticity and adult hippocampal neurogenesis. Acta Neuropathol Commun. 2020;8:155.
   PubMed Web of Science ®Google Scholar
• May S, Hornburg D, Schludi MH, et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 2014;128:485–503.
   PubMed Web of Science ®Google Scholar
• Morrice JR, Gregory-Evans CY, Shaw CA. Animal models of amyotrophic lateral sclerosis: A comparison of model validity. Neural Regen Res. 2018;13:2050–2054.
   PubMed Web of Science ®Google Scholar
• Moens TG, Partridge L, Isaacs AM. Genetic models of C9orf72: what is toxic? Curr Opin Genet Dev. 2017;44:92–101.
   PubMed Web of Science ®Google Scholar
• Batra R, Lee CW. Mouse models of C9orf72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis/frontotemporal dementia. Front Cell Neurosci. 2017;11:196.
   PubMed Web of Science ®Google Scholar
• Sareen D, O'Rourke JG, Meera P, et al. Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149.
   PubMed Web of Science ®Google Scholar
• Zhang K, Donnelly CJ, Haeusler AR, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56–61.
   PubMed Web of Science ®Google Scholar
• Devlin AC, Burr K, Borooah S, et al. Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6:5999.
   PubMed Web of Science ®Google Scholar
• Almeida S, Krishnan G, Rushe M, et al. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathol. 2019;138:1099–1101.
   PubMed Web of Science ®Google Scholar
• Bursch F, Kalmbach N, Naujock M, et al. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations. Hum Mol Genet. 2019;28:2835–2850.
   PubMed Web of Science ®Google Scholar
• Dafinca R, Barbagallo P, Farrimond L, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD. Stem Cell Reports. 2020;14:892–908.
   PubMed Web of Science ®Google Scholar
• Tang X, Toro A, T G S, et al. Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD. Mol Neurodegener. 2020;15:34.
   PubMed Web of Science ®Google Scholar
• Ugolino J, Ji YJ, Conchina K, et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 2016;12:e1006443.
   PubMed Web of Science ®Google Scholar
• Atanasio A, Decman V, White D, et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep. 2016;6:23204.
   PubMed Web of Science ®Google Scholar
• Burberry A, Suzuki N, Wang JY, et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med. 2016;8:347ra393.
   Web of Science ®Google Scholar
• Belzil VV, Katzman RB, Petrucelli L. ALS and FTD: an epigenetic perspective. Acta Neuropathol. 2016;132:487–502.
   PubMed Web of Science ®Google Scholar
• Barres BA, Barde Y. Neuronal and glial cell biology. Curr Opin Neurobiol. 2000;10:642–648.
   PubMed Web of Science ®Google Scholar
• Jensen BK, Schuldi MH, McAvoy K, et al. Synaptic dysfunction induced by glycine-alanine dipeptides in C9orf72-ALS/FTD is rescued by SV2 replenishment. EMBO Mol Med. 2020;12:e10722.
   PubMed Web of Science ®Google Scholar
• Atkinson RA, Fernandez-Martos CM, Atkin JD, et al. C9ORF72 expression and cellular localization over mouse development. Acta Neuropathol Commun. 2015;3:59.
   PubMed Web of Science ®Google Scholar
• Frick P, Sellier C, Mackenzie IR, et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol Commun. 2018;6:72.
   PubMed Web of Science ®Google Scholar
• O’Rourke JG, Bogdanik L, Yanez A, et al. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324–1329.
   PubMed Web of Science ®Google Scholar
• Burberry A, Wells MF, Limone F, et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature. 2020;582:89–94.
   PubMed Web of Science ®Google Scholar
• McCauley ME, O'Rourke JG, Yanez A, et al. C9orf72 in myeloid cells suppresses STING-induced inflammation. Nature. 2020;585:96–101.
   PubMed Web of Science ®Google Scholar
• Lan Y, Sullivan PM, Hu F. SMCR8 negatively regulates AKT and MTORC1 signaling to modulate lysosome biogenesis and tissue homeostasis. Autophagy. 2019;15:871–885.
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, et al. Network organization of the human autophagy system. Nature. 2010;466:68–76.
   PubMed Web of Science ®Google Scholar
• Wong PM, Puente C, Ganley IG, et al. ULK1 complex: sensing nutrient signals for autophagy activation. Autophagy. 2013;9:124–137.
   PubMed Web of Science ®Google Scholar
• Lin MG, Hurley JH. Structure and function of the ULK1 complex in autophagy. Curr Opin Cell Biol. 2016;39:61–68.
   PubMed Web of Science ®Google Scholar
• Ho WY, Tai YK, Chang JC, et al. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy. 2019;15:827–842.
   PubMed Web of Science ®Google Scholar
• Amick J, Tharkeshwar AK, Amaya C, et al. WDR41 supports lysosomal response to changes in amino acid availability. Mol Biol Cell. 2018;29:2213–2227.
   PubMed Web of Science ®Google Scholar
• Amick J, Tharkeshwar AK, Talaia G, et al. PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation. J Cell Biol. 2020;219: DOI:10.1083/jcb.201906076
   PubMed Web of Science ®Google Scholar
• Liang C, Shao Q, Zhang W, wet al. Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS/FTD mouse models. Hum Mol Genet. 2019;28:3940–3953.
   PubMed Web of Science ®Google Scholar
• Amick J, Ferguson SM. C9orf72: at the intersection of lysosome cell biology and neurodegenerative disease. Traffic. 2017;18:267–276.
   PubMed Web of Science ®Google Scholar
• Lawrence RE, Fromm SA, Fu Y, et al. Structural mechanism of a Rag GTPase activation checkpoint by the lysosomal folliculin complex. Science. 2019;366:971–977.
   PubMed Web of Science ®Google Scholar
• Vigil D, Cherfils J, Rossman KL, et al. Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer. 2010;10:842–857.
   PubMed Web of Science ®Google Scholar
• Shaw RJ. mTOR signaling: RAG GTPases transmit the amino acid signal. Trends Biochem Sci. 2008;33:565–568.
   PubMed Web of Science ®Google Scholar
• Lamber EP, Siedenburg AC, Barr FA. Rab regulation by GEFs and GAPs during membrane traffic. Curr Opin Cell Biol. 2019;59:34–39.
   PubMed Web of Science ®Google Scholar
• Homma Y, Hiragi S, Fukuda M. Rab family of small GTPases: an updated view on their regulation and functions. Febs J. 2020. DOI:10.1111/febs.15453
   PubMed Web of Science ®Google Scholar
• Muller MP, Goody RS. Molecular control of Rab activity by GEFs, GAPs and GDI. Small GTPases. 2018;9:5–21.
   PubMedGoogle Scholar
• Kiral FR, Kohrs FE, Jin EJ, et al. Rab GTPases and membrane trafficking in neurodegeneration. Curr Biol. 2018;28:R471–R486.
   PubMed Web of Science ®Google Scholar
• Tsun ZY, Bar-Peled L, Chantranupong L, et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell. 2013;52:495–505.
   PubMed Web of Science ®Google Scholar
• Shen K, Huang RK, Brignole EJ, et al. Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes. Nature. 2018;556:64–69.
   PubMed Web of Science ®Google Scholar
• Iyer S, Subramanian V, Acharya KR. C9orf72, a protein associated with amyotrophic lateral sclerosis (ALS) is a guanine nucleotide exchange factor. PeerJ. 2018;6:e5815.
   PubMed Web of Science ®Google Scholar
• Sivadasan R, Hornburg D, Drepper C, et al. C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons. Nat Neurosci. 2016;19:1610–1618.
   PubMed Web of Science ®Google Scholar
• Chaineau M, Ioannou MS, McPherson PS. Rab35: gEFs, GAPs and effectors. Traffic. 2013;14:1109–1117.
   PubMed Web of Science ®Google Scholar
• Kiontke S, Langemeyer L, Kuhlee A, et al. Architecture and mechanism of the late endosomal Rab7-like Ypt7 guanine nucleotide exchange factor complex Mon1-Ccz1. Nat Commun. 2017;8:14034.
   PubMed Web of Science ®Google Scholar
• Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev. 2011;91:119–149.
   PubMed Web of Science ®Google Scholar
• Petit CS, Roczniak-Ferguson A, Ferguson SM. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. J Cell Biol. 2013;202:1107–1122.
   PubMed Web of Science ®Google Scholar
• Nookala RK, Langemeyer L, Pacitto A, et al. Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer. Open Biol. 2012;2:120071.
   PubMed Web of Science ®Google Scholar
• De Franceschi N, Wild K, Schlacht A, et al. Longin and GAF domains: structural evolution and adaptation to the subcellular trafficking machinery. Traffic. 2014;15:104–121.
   PubMed Web of Science ®Google Scholar
• Talaia G, Amick J, Ferguson SM. Receptor-like role for PQLC2 amino acid transporter in the lysosomal sensing of cationic amino acids. bioRxiv. 2020.
   Google Scholar
• Aoe T, Cukierman E, Lee A, et al. The KDEL receptor, ERD2, regulates intracellular traffic by recruiting a GTPase-activating protein for ARF1. Embo J. 1997;16:7305–7316.
   PubMed Web of Science ®Google Scholar
• Garcia-Mata R, Szul T, Alvarez C, et al. ADP-ribosylation factor/COPI-dependent events at the endoplasmic reticulum-Golgi interface are regulated by the guanine nucleotide exchange factor GBF1. Mol Biol Cell. 2003;14:2250–2261.
   PubMed Web of Science ®Google Scholar
• Ge L, Melville D, Zhang M, et al. ER-Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis. Elife. 2013;2:e00947.
   PubMed Web of Science ®Google Scholar
• Pang W, Hu F. Cellular and physiological functions of C9ORF72 and implications for ALS/FTD. J Neurochem. 2020. DOI:10.1111/jnc.15255
   Web of Science ®Google Scholar
• Wang M, et al. Wang H, Tao Z, C9orf72 associates with inactive Rag GTPases and regulates mTORC1-mediated autophagosomal and lysosomal biogenesis. Aging Cell. 2020;19:e13126.
   PubMed Web of Science ®Google Scholar
• Schumann T, Konig J, Henke C, et al. Solute carrier transporters as potential targets for the treatment of metabolic disease. Pharmacol Rev. 2020;72:343–379.
   PubMed Web of Science ®Google Scholar
• Hadley B, Litfin T, Day CJ, et al. Nucleotide sugar transporter SLC35 family structure and function. Comput Struct Biotechnol J. 2019;17:1123–1134.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Sun K, et al. SLC transporter in nutrient and metabolic sensing, regulation, and drug development. J Mol Cell Biol. 2019;11:1–13.
   PubMed Web of Science ®Google Scholar
• Shinde SR, Maddika S. Post translational modifications of Rab GTPases. Small GTPases. 2018;9:49–56.
   PubMedGoogle Scholar
• Salaun C, Greaves J, Chamberlain LH. The intracellular dynamic of protein palmitoylation. J Cell Biol. 2010;191:1229–1238.
   PubMed Web of Science ®Google Scholar
• Kong E, Peng S, Chandra G, et al. Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-ras product and growth-associated protein-43. J Biol Chem. 2013;288:9112–9125.
   PubMed Web of Science ®Google Scholar
• Meinnel T, Dian C, Giglione C. Myristoylation, an ancient protein modification mirroring eukaryogenesis and evolution. Trends Biochem Sci. 2020;45:619–632.
   PubMed Web of Science ®Google Scholar
• Schrodinger LLC The PyMOL molecular graphics system, version 1.8 (2015).
   Google Scholar
• Chi X, Jin X, Chen Y, et al. Structural insights into the gating mechanism of human SLC26A9 mediated by its C-terminal sequence. Cell Discov. 2020;6:55.
   PubMed Web of Science ®Google Scholar